DSpace Repository

Endothelial dysfunction in patients with ankylosing spondylitis after covid-19

Show simple item record

dc.contributor.author Rakhimova M., Akhmedov Kh., Rakhimova O.
dc.date.accessioned 2024-12-17T01:10:30Z
dc.date.available 2024-12-17T01:10:30Z
dc.date.issued 2024
dc.identifier.citation Toshkent en_US
dc.identifier.issn 2181-7812
dc.identifier.uri http://repo.tma.uz/xmlui/handle/1/371
dc.description.abstract Study of endothelial dysfunction against the background of systemic inflammation in patients with an- kylosing spondylitis who have had COVID-19. Material and methods: The study included 80 patients diagnosed with ankylosing spondylitis according to the modified New York criteria and EULAR. All patients were divided into 2 groups: 1st group - 40 patients with ankylosing spondylitis without a post-Covid period, 2nd - 40 patients with ankylosing spon- dylitis and a post-COVID period. The control group consist- ed of 40 healthy people with no history of acute or chronic diseases. Results: In patients with ankylosing spondylitis, survivors of COVID-19 and healthy people, there was no significant correlation between gender, age, serum lipids, smoking habit, C-reactive protein level and disease activity, although for some of of these variables, this may have oc- curred due to the small number of subjects included in the study. Conclusions: The lack of correlation between FMD indicators and disease activity should be confirmed by fur- ther studies with a larger number of subjects. en_US
dc.language.iso en en_US
dc.relation.ispartofseries UDK;616-008:616.13-02:612.017.1-616-074-08
dc.subject ankylosing spondylitis, COVID-19, endo- thelial dysfunction. en_US
dc.title Endothelial dysfunction in patients with ankylosing spondylitis after covid-19 en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account